Fevaxyn Quatrifel Suspensie voor injectie
Fevaxyn Quatrifel Suspensie voor injectie
Not authorised
- Felid herpesvirus 1, strain 605, Inactivated
- Feline panleucopenia virus, strain CU4, Inactivated
- Feline calicivirus, strain 255, Inactivated
- Chlamydia felis, strain Cello, Inactivated
Product identification
Medicine name:
Fevaxyn Quatrifel Suspensie voor injectie
Fevaxyn Quatrifel Suspension injectable
Fevaxyn Quatrifel Injektionssuspension
Active substance:
- Felid herpesvirus 1, strain 605, Inactivated
- Feline panleucopenia virus, strain CU4, Inactivated
- Feline calicivirus, strain 255, Inactivated
- Chlamydia felis, strain Cello, Inactivated
Target species:
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Felid herpesvirus 1, strain 605, Inactivated1.39/relative potency1.00millilitre(s)
-
Feline panleucopenia virus, strain CU4, Inactivated8.50/relative potency1.00millilitre(s)
-
Feline calicivirus, strain 255, Inactivated1.26/relative potency1.00millilitre(s)
-
Chlamydia felis, strain Cello, Inactivated1.69/relative potency1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cat
-
All relevant tissuesno withdrawal periodFrench: Sans objet. ; Dutch: Niet van toepassing.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI06AL01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Belgium
Package description:
- Fevaxyn Quatrifel 10 Pre-filled syringes with 1 ml Suspension for injection
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V174912
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.